Lumos Pharma, Inc. Common Stock
LUMO
LUMO was delisted on the 11th of December, 2024.
35 hedge funds and large institutions have $4.82M invested in Lumos Pharma, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 5 closing their positions.
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
3% less funds holding
Funds holding: 36 → 35 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
21% less capital invested
Capital invested by funds: $6.14M → $4.82M (-$1.32M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$36.2K |
| 2 |
AI
Atria Investments
Charlotte,
North Carolina
|
+$27.9K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$14.1K |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$8.68K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$8.09K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Blackstone Inc
New York
|
-$222K |
| 2 |
Two Sigma Advisers
New York
|
-$90K |
| 3 |
Two Sigma Investments
New York
|
-$51.3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$10.5K |
| 5 |
Renaissance Technologies
New York
|
-$5.68K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| $4.18K | – | – | – |
|
|
WFA
27
West Financial Advisors
Des Moines,
Iowa
| $1.82K | – | – | – |
|
|
RWMG
28
Redwood Wealth Management Group
Medford,
New Jersey
| $1.16K | +$1.29K | +500 | New |
|
29
Osaic Holdings
Scottsdale,
Arizona
| $720 | +$403 | +156 | +101% |
|
30
Morgan Stanley
New York
| $643 | +$287 | +111 | +67% |
|
|
IAIM
31
International Assets Investment Management
Orlando,
Florida
| $88 | +$98 | +38 | New |
|
32
JP Morgan Chase
New York
| $30 | -$72 | -28 | -68% |
|
|
LOIP
33
Live Oak Investment Partners
Austin,
Texas
| $26 | – | – | – |
|
34
Jones Financial Companies
Des Peres,
Missouri
| $9 | +$10 | +4 | New |
|
35
Qube Research & Technologies (QRT)
London,
United Kingdom
| $7 | – | – | – |
|
|
36
Blackstone Inc
New York
| – | -$222K | -78,624 | Closed |
|
|
37
Two Sigma Advisers
New York
| – | -$90K | -31,900 | Closed |
|
|
38
UBS Group
Zurich,
Switzerland
| – | -$10.5K | -3,733 | Closed |
|
39
Group One Trading
Chicago,
Illinois
| – | -$423 | -150 | Closed |
|
|
GRP
40
Global Retirement Partners
San Rafael,
California
| – | -$31 | -11 | Closed |
|
LUMO Hedge Fund Activity: Q2 2024 in Review
35 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Lumos Pharma, Inc. Common Stock (LUMO) for Q2 2024, worth a combined $4.82M — down 21% from $6.14M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of LUMO and 4 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 8 added.
The largest buyer was Private Advisor Group, adding an estimated $36.2K. The largest seller was Blackstone Inc, exiting entirely with an estimated $222K sold.
- 35 institutional investors held Lumos Pharma, Inc. Common Stock (LUMO) as of Q2 2024, down from 36 in Q1 2024.
- Funds reported $4.82M of Lumos Pharma, Inc. Common Stock stock for Q2 2024, down 21% quarter-over-quarter.
- 4 funds opened new Lumos Pharma, Inc. Common Stock positions in Q2 2024 and 5 closed out, a net change of -1 holder.
- The largest Lumos Pharma, Inc. Common Stock buyer in Q2 2024 was Private Advisor Group, an estimated $36.2K added.
- The largest Lumos Pharma, Inc. Common Stock seller in Q2 2024 was Blackstone Inc, an estimated $222K sold.
Based on aggregated 13F filings for Q2 2024.